Epidemiology, Vaccines and Surveillance of COVID-19
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: 20 March 2027 | Viewed by 329
Special Issue Editors
Interests: polio eradication; vaccines; immunization; vaccine-preventable diseases
Interests: polio eradication; vaccines; immunization; vaccine-preventable diseases
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue in Vaccines on the Epidemiology, Vaccinology, and Surveillance of COVID-19. This Special Issue aims to discuss the evolving epidemiology of COVID-19, from its advent at the onset of the pandemic to the current state of affairs. It will also examine measures taken to mitigate the spread and impact of the disease, including surveillance and testing measures, as well as the impact of vaccines, including their safety, immunogenicity, efficacy, and effectiveness.
In this Special Issue, original research articles, commentaries, and reviews are welcome. Research areas may include (but are not limited to) the following: COVID-19 epidemiology, vaccinology, surveillance, and case detection and management.
We look forward to receiving your contributions.
Dr. Chukwuma Mbaeyi
Dr. Abdinoor Mohamed
Dr. Nishant Kishore
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- coronavirus
- SARS CoV-2
- epidemiology
- surveillance
- case detection
- vaccines
- vaccinology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
